Image

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Evaluating Deucravacitinib's effects in lupus patients compared to placebo.

Recruiting
18-75 years
All
Phase 3

This study is about testing a medicine called Deucravacitinib for people with Systemic Lupus Erythematosus (SLE). SLE is a condition where the body’s defense system attacks its own tissues. The study compares Deucravacitinib with a placebo (a harmless pill that has no medicine) to see which works better and is safer.

To join, you must have SLE for at least 24 weeks and meet certain health criteria. You need to be on SLE treatment for at least 12 weeks. If you have other autoimmune diseases, serious infections, or specific health conditions, you cannot join.

  • Duration: The study will require regular visits and monitoring, but the exact length is not specified here.
  • Participation: You must have a stable dose of SLE medicine before joining and during the study.
  • Risks: You cannot join if you have serious infections or other autoimmune diseases.

This study helps researchers find better treatments for SLE. Talk to your doctor to see if it’s right for you.

Study details
    Systemic Lupus Erythematosus

NCT05620407

Bristol-Myers Squibb

9 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.